Search results
Results from the WOW.Com Content Network
Phage display is also a widely used method for in vitro protein evolution (also called protein engineering). As such, phage display is a useful tool in drug discovery. It is used for finding new ligands (enzyme inhibitors, receptor agonists and antagonists) to target proteins.
Phage display methods are one option for screening proteins. This method involves the fusion of genes encoding the variant polypeptides with phage coat protein genes. Protein variants expressed on phage surfaces are selected by binding with immobilized targets in vitro.
Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. OCLC 43903550, ISBN 0-87969-740-7; Birge, E. A. 2000. Bacterial and Bacteriophage Genetics. Springer-Verlag, New York. OCLC 41273243, ISBN 0-387-23919-7; Stahl, F. W. 2000. We Can Sleep Later: Alfred D. Hershey and the Origins of Molecular Biology.
Phage typing is a phenotypic method that uses bacteriophages ("phages" for short) for detecting and identifying single strains of bacteria. [1] Phages are viruses that infect bacteria and may lead to bacterial cell lysis . [ 2 ]
Protein methods are the techniques used to study proteins.There are experimental methods for studying proteins (e.g., for detecting proteins, for isolating and purifying proteins, and for characterizing the structure and function of proteins, [1] often requiring that the protein first be purified).
General laboratory stands, racks, filter paper, reagents, etc. Induction coils: as a source of high voltage electricity Cathode ray oscilloscope ' Recording kymograph: historically, used in human or animal experiments to measure and record data Long extension kymograph: historically, used in or human animal experiments to measure and record data
John McCafferty is a British scientist, one of the founders of Cambridge Antibody Technology alongside Sir Gregory Winter and David Chiswell. He is well known as one of the inventors of scFv antibody fragment phage display, [1] a technology that revolutionised the monoclonal antibody drug discovery.
The resulting phage particles that are produced contain the single-stranded phagemids and are used to infect XL-1 Blue cells. [2] The double-stranded phagemids are subsequently collected from these XL-1 Blue cells, essentially reversing the process used to produce the original library phage.